Territory Business Manager | Hackensack NJ

Target salary: $110,000 - $130,000

About Scilex

SCILEX HOLDING COMPANY (Nasdaq: SCLX, “Scilex”), majority-owned by Sorrento, is dedicated to the development and commercialization of non-opioid pain management products. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.

The company’s lead product ZTlido® (lidocaine topical system) 1.8%, is a marketed prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain. ZTlido® possesses novel delivery and adhesion technology designed to address many of the limitations of current prescription lidocaine patches by providing significantly improved adhesion and continuous pain relief throughout the 12-hour administration period. Click here for ZTLido’s Important Safety Information and US Prescribing Information.

We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYBTM, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. We launched ELYXYBTM in the U.S. in April 2023 and are planning to commercialize GLOPERBA in 2023.

Our three product candidates are (i) SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (“SEMDEXATM”), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica and has received Fast Track Status from the FDA. Currently there is no FDA approved non-opioid epidural injection to treat lumbosacral radicular pain, or sciatica; (ii) SP-103 (lidocaine topical system) 5.4%, (“SP-103”), a Phase 2, next-generation, triple-strength formulation of ZTlido, for the treatment of low back pain (“LBP”) and has received Fast Track Status from the FDA; and (iii) SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (“SP-104”), a novel low-dose delayed-release naltrexone hydrochloride being developed for the treatment of fibromyalgia. If these product candidates are approved by the FDA, we believe each of them could become the treatment option for their respective indications in the United States.

SCILEX is committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them the most. Scilex Pharmaceuticals and Semnur Pharmaceuticals are wholly-owned subsidiaries of Scilex Holding Company.

Role and Responsibilities

• Create and implement business plans and tactical strategies for their territories.
• Manage geographic territory to achieve individual, territory and company goals for sales, market share, call metrics, appropriate sample distribution, etc.
• Manage daily sales call activity according to defined expectations, with the purpose of influencing customers and building and driving product sales:
• Promote product(s) via face-to-face interactions with assigned HCP targets and Pharmacies while engaging them in in-depth program discussions/presentations.
• Profile and manage a list of key HCP targets and Pharmacies to provide value-added benefits to grow product volume.
• Sample and provide Co-Pay cards to HCP’s based on the business needs identified by the TBM’s.
• Develop call plan for the territory and make the number of calls on physicians and pharmacies as per the call plan.
• Listen and respond appropriately to customer needs and questions.
• Effectively and persuasively communicate with customers using effective selling, listening and negotiation skills, proper terminology, and approved messaging.
• Maintain thorough knowledge of product(s).
• Sample as per the company policy and record distribution of samples in a compliant way.
• Verify and complete required data entry in CRM systems, such as details of the target’s responses and any follow-through actions.
• Regularly and timely communication with Regional Business Director as required.
• Create and maintain a positive relationship with customers.
• Prepare reports for management as needed.
• Fully comply with all laws, regulations and Scilex Policies, Code of Conduct, all privacy and data guidelines, relevant state and federal laws and regulations as well as the Company’s policies and procedures in connection with the performance of the job function, including, but not limited to, the Federal Food, Drug, and Cosmetic Act, the Prescription Drug Act, Marketing Act, the PhRMA Code related to interactions w/healthcare providers, and the Federal Anti-Kickback Statute.
• Participate in teleconferences and live National, regional and district meetings and training sessions and represent Scilex at National and/or local conventions when requested.
• Perform special projects and assignments as directed by the manager
• Qualifications and Education Requirements
• Previous experience and success in sales, customer service, or other related fields
• 4 Year College Degree
• Able to work large geography.
• Familiarity with CRM platforms
• Ability to build rapport with clients.
• Strong negotiation & decision-making skills
• Deadline and detail-oriented
• Ability and willingness to take direction from multiple sources and complete instructed tasks within deadlines provided.
• Can quickly establish customer relationships.
• Maintains a competent knowledge of product knowledge.
• Excellent verbal, written and interpersonal communication skills.
• A valid driver's license and safe driving record
• Good organizational and planning skills.
• Reside within the assigned geography.
• Willingness to travel, some overnight travel may be required.

Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities

The contractor will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, or (c) consistent with the contractor’s legal duty to furnish information. 41 CFR 60-1.35(c)